Under construction – not a live service
Sign in
Taking people in SpainNo phase

Computer-based cognitive training program for people with long-lasting problems after COVID-19

Tests a supervised computer training program in adults with post-COVID-19 condition.

Plain-language title generated from the registry record
Registry title: SuperCAP Program to Improve Cognition and Daily Functioning in Post-COVID-19 Condition

Key facts

Where
Badalona, SpainSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 65 years old?

Source: NCT07530757, who can take part

Where in Spain

  • Fundació Lluita contra les Infeccions - Hospital Universitari Germans Trias i PujolBadalona, SpainTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia
Trial code
NCT07530757
Record updated
11 September 2026
Original description
The goal of this study is to determine whether the SuperCAP intervention program is superior to control in reducing disability from baseline to the post-intervention assessment in people with Post-COVID-19 Condition.Read full original descriptionShow less

Randomized Controlled Trial to Assess the Efficacy of a Supervised Computerized Active Program (SuperCAP) to Improve Cognition and Daily Functioning in People With Post-COVID-19 Condition

The goal of this study is to determine whether the SuperCAP intervention program is superior to control in reducing disability from baseline to the post-intervention assessment in people with Post-COVID-19 Condition.

The main question it aims to answer is whether participants assigned to SuperCAP experience a greater reduction in disability, defined as an improvement of at least 5 points on the WHODAS 2.0 from baseline to the post-intervention visit, compared with participants in the control group.

Participants assigned to the SuperCAP intervention will undergo a series of sessions that include psychoeducation, adaptive cognitive training exercises, fatigue self-management strategies, and multidisciplinary content.

Inclusion: Diagnosis of PCC, defined as the presence of three or more symptoms associated with COVID-19 infection for at least three months, not explained by other diseases; Age 18 to 65 years; Willingness to participate in an app-based intervention program aimed at improving daily Functioning in People Living with PCC; Evidence of patient-reported cognitive difficulties emerging after COVID-19, operationalized as a WHODAS 2.0 Cognition Domain (D1) score > 6 at baseline via RedCAP; Digital proficiency defined as scoring ≥4 on MDPQ-16 item 2a (sending emails) and ≥3 on item 6a (using the device's app store) via RedCAP; Self-reported ability to use a mobile application for approximately 15 minutes per day, 5 days per week, considering their current symptoms; Possession of a personal smartphone compatible with the study mobile application (eSalut), with sufficient storage space and operating system version required for installation.

Exclusion: Prior use of the SuperCAP program; Any condition that, in the investigator's opinion, could make participation unsafe, complicate interpretation of study results, interfere with achievement of study objectives, or otherwise affect the participant's ability to complete the study; Inability to undergo neuropsychological tests or additional assessments; Current participation in a trial or program aimed at improving PCC symptoms.

ClinicalTrials.gov NCT07530757